Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new blog series, researchers in the OxImmnuo Literature initiative select papers that cover topics in COVID-19 research that they think may be of interest to the wider public and summarise them for a more general audience

Stack of academic papers with text highlighted and a pen resting on top

The OxImmuno Literature initiative has collected together a team of around 100 researchers from the Medical Sciences Division of the University of Oxford to read, review and summarise recent COVID-19 research from all round the world in order to support the researchers working on COVID-19 here at the University of Oxford.

Research papers are peer reviewed, ie. read and checked by other scientists, before they are published in research journals. As COVID-19 is such a new phenomenon most of the research has not yet had time to be peer reviewed but, in order to help other scientists working on COVID-19, research is still made available as a pre-print for other researchers to read.

Our summaries of some of these pre-prints and papers can be read here. However, these are written for other researchers. We have selected a few papers that cover topics in COVID-19 research that we think may be of interest to the wider public and have summarised them for a more general audience and included more background information. These summaries, with links to the original research, can be found in this, our new blog.

The blogs are available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.